Start Here What HIV neuropathy is and what actually helps
The short version: Peripheral neuropathy — burning, tingling, numbness, or stabbing pain in feet and hands — is one of the most common long-term side effects of HIV and older HIV medications. Newer ART regimens have made it much less common, but it still affects a real share of long-term survivors and people who were on older nucleoside drugs like d4T or ddI. Treatment centers on catching it early, ruling out other causes (diabetes, B12 deficiency, alcohol), and combining medication with lifestyle steps that protect the nerves you still have.
← Learning HubWhat Is Peripheral Neuropathy?
Peripheral neuropathy is damage to the peripheral nerves — the vast network of nerves outside the brain and spinal cord that carry signals between the central nervous system and the rest of the body. These nerves control sensation, movement, and autonomic functions like heart rate and digestion. When they are damaged, those signals go wrong: pain arrives without injury, sensation disappears where it should be present, or the body loses the ability to respond to temperature, pressure, or position normally.
Neuropathy frequency differs across populations and treatment eras. Older studies with substantial exposure to neurotoxic medicines cannot establish a lifetime risk for everyone receiving modern ART.[5]
Despite its prevalence, neuropathy in PLHIV is frequently undertreated. Patients often don't report it because they assume chronic pain is just part of living with HIV. Providers often don't screen for it systematically because the appointment is full of other concerns. The result is a significant burden of pain and disability that goes unaddressed — affecting quality of life, sleep, mobility, mental health, and medication adherence.
Neuropathy pain is real, it is measurable, and it is treatable — not always curable, but treatable. If you are living with burning, numbness, or nerve pain and have never had a formal neuropathy evaluation, that conversation with your provider is overdue.
Two Types — HIV-Associated vs. Drug-Induced
HIV-related nerve injury and toxicity from certain older HIV medicines are two important causes. Diabetes, deficiencies, other medicines, and unrelated nerve disorders also need consideration.[1]
- Distal Sensory Polyneuropathy — the most common form
- Caused by HIV itself and the chronic neuroinflammation it drives
- More common with advanced disease and lower CD4 counts — but can occur at any stage
- Typically starts in the feet and lower legs and may progress upward
- Improves with effective ART — but may not resolve completely even with viral suppression
- The longer HIV went untreated, the more likely permanent nerve damage has occurred
- Antiretroviral Toxic Neuropathy — caused by specific older ART medications
- Primarily associated with stavudine (d4T), didanosine (ddI), and zalcitabine (ddC) — older nucleoside reverse transcriptase inhibitors (NRTIs) now rarely used
- Can develop weeks to months after starting the causative drug
- Can resemble HIV-associated DSP; symptoms alone do not reliably identify the cause
- Stopping the offending drug may allow partial recovery — but damage can be permanent
- Long-term survivors who took these older regimens may carry lasting neuropathy from medications no longer used
Other Contributing Factors
Several conditions that are more common in PLHIV can independently cause or worsen peripheral neuropathy:
- Diabetes: Diabetic neuropathy is one of the most common causes of peripheral neuropathy generally — and PLHIV have elevated diabetes risk from both HIV inflammation and some ART regimens
- Vitamin B12 deficiency: Deficiency is more common in PLHIV and causes neuropathy that can mimic or compound HIV-associated DSP — and is highly treatable
- Alcohol use: Chronic alcohol use causes peripheral neuropathy independently — and compounds HIV-associated nerve damage
- Hepatitis C coinfection: HCV is independently associated with peripheral neuropathy, particularly cryoglobulinemia-related neuropathy
- Vitamin deficiencies: Review nutrition and supplements with your clinician. Testing should reflect your history; extra vitamins are not an established treatment when no deficiency is present.
What It Feels Like — Symptoms and Presentation
Peripheral neuropathy presents differently in different people — and the variation in symptoms is one reason it is often missed or misidentified. The classic presentation in PLHIV is bilateral symptoms beginning in the feet and lower legs — the "stocking and glove" distribution — but not everyone presents classically.
Common Symptoms of Peripheral Neuropathy in PLHIV
- Burning pain: Often described as feet or legs feeling like they are on fire — frequently worse at night and when lying down
- Pins and needles: Persistent tingling or prickling sensations, particularly in the feet and toes
- Numbness: Reduced or absent sensation in the feet, hands, or both — can feel like wearing socks or gloves that aren't there
- Allodynia: Pain from stimuli that should not be painful — the weight of a bedsheet on the feet, walking barefoot on a smooth floor. This symptom is particularly disruptive to sleep and daily function
- Weakness: In more advanced cases, muscle weakness in the feet and ankles, causing balance problems or difficulty walking
- Loss of reflexes: Reduced or absent ankle reflexes — often one of the first signs a clinician will find on examination
- Autonomic symptoms: Less common but possible — sweating abnormalities, blood pressure changes when standing, digestive symptoms
The timing and pattern of symptoms can help distinguish between types. HIV-associated DSP tends to develop gradually over months to years. Drug-induced neuropathy may develop more rapidly and can actually worsen briefly after stopping the offending medication — a phenomenon called "coasting" — before beginning to improve.
If your symptoms are primarily in your hands rather than your feet, or if they are asymmetric (much worse on one side), it is worth discussing this specifically with your provider — these patterns may suggest a different cause that needs separate evaluation.
Getting Diagnosed — What to Expect
Neuropathy diagnosis in PLHIV begins with your history and a physical examination — and a provider who asks the right questions. If your provider has not specifically asked about numbness, burning, tingling, or pain in your feet and hands, raise it yourself. Use specific language: not "my feet hurt" but "I have burning pain in both feet that is worse at night."
The Diagnostic Workup
- Neurological examination: Testing reflexes, vibration sense, light touch, temperature sensation, and position sense in the feet and legs — the physical exam is often sufficient to identify neuropathy
- Lab work: Tests are tailored to the history and may include B12, blood glucose, thyroid, kidney, and liver assessment. HbA1c can underestimate blood glucose during ART, so it should not be the only diabetes test.[11]
- Nerve conduction studies (NCS) and electromyography (EMG): Specialized tests that measure the speed and strength of nerve signals. Can help confirm diagnosis and distinguish between types — particularly useful when the picture is unclear or symptoms are atypical
- Skin punch biopsy: A small skin sample from the leg can measure the density of small nerve fibers — particularly useful for diagnosing small fiber neuropathy that may not show up on standard NCS/EMG
- Medication history review: A careful review of current and past ART regimens is essential — particularly for long-term survivors who may have taken older nucleoside analogs
Treatment Options — What the Evidence Supports
Recovery depends on the cause and the extent of injury. Some neuropathies improve when a treatable cause is addressed; others leave lasting symptoms. Pain care aims to improve comfort, sleep, and function, with benefits and side effects reviewed over time.
| Treatment | Evidence in HIV Neuropathy | Notes |
|---|---|---|
| ART optimization | First-line — effective ART reduces HIV-driven neuroinflammation and can slow or partially reverse HIV-associated DSP. Switching away from causative older NRTIs essential for drug-induced neuropathy. | Discuss with HIV provider before any regimen change. The amount and timing of improvement vary; viral suppression does not guarantee nerve recovery. |
| Gabapentin (Neurontin) | Moderate evidence in HIV neuropathy — reduces pain intensity and improves sleep in clinical trials. HIVMA/IDSA recommends it as a first-line oral option, while the underlying trial evidence is small.[7] | Takes 2–4 weeks for full effect. Dose titration required. Sedation is a common side effect — can be used strategically for nighttime dosing to help sleep. |
| Pregabalin (Lyrica) | Effective for some other neuropathic pain conditions, but an HIV-specific randomized trial found no superiority over placebo. Do not assume diabetic-neuropathy results apply to HIV neuropathy.[8] | Schedule V controlled substance. More predictable absorption than gabapentin. Cost can be a barrier — discuss generic options. |
| Duloxetine (Cymbalta) | FDA-approved for diabetic neuropathy; direct HIV-neuropathy evidence is limited, and use relies partly on evidence from other neuropathic-pain conditions. Has the additional benefit of treating co-occurring depression. | Useful when neuropathy and depression co-occur — addresses both. Takes 4–6 weeks for full antidepressant effect. |
| Tricyclic antidepressants (amitriptyline, nortriptyline) | Long-established use in neuropathic pain. HIV-specific trials have not established benefit over placebo; use may be considered after other options based on broader neuropathic-pain evidence. More side effects than newer agents — sedation, dry mouth, cardiac effects. | Low-dose (10–25mg) at bedtime is common approach. Avoid in people with cardiac disease or certain medication interactions. Check with HIV pharmacist. |
| Topical lidocaine / capsaicin | Evidence differs by product. The clinician-applied 8% capsaicin patch has HIV-specific evidence; low-strength creams and topical lidocaine should not be assumed equivalent.[10] | Good option when systemic medications cause unacceptable side effects. Capsaicin patch application is temporarily painful — managed with topical anesthetic beforehand. |
| Vitamin B12 supplementation | If B12 deficiency is present — treatment is essential and can produce significant improvement. If B12 is normal, supplementation does not improve neuropathy. | Check B12 level before supplementing. Oral B12 is effective for most; intramuscular injection may be needed for severe deficiency or absorption problems. |
Opioids Are Not First-Line for Neuropathic Pain
Opioid medications are generally not recommended as first-line treatment for peripheral neuropathy — they have limited efficacy for neuropathic pain specifically, carry significant risks of dependence and side effects, and do not address the underlying nerve damage. If you are being offered opioids as the primary treatment for neuropathic pain without a trial of the evidence-based options above, it is worth asking your provider about the alternatives. A referral to a neurologist or pain management specialist may be appropriate if first-line treatments have been inadequate.
Living With Neuropathy — Day to Day
Management of peripheral neuropathy extends beyond medication. The daily experience of living with neuropathic pain — particularly when it disrupts sleep, limits mobility, and affects mental health — requires a comprehensive approach that medications alone cannot provide.
Practical Strategies That Help
- Foot protection: Wear well-fitting shoes, inspect numb feet daily, and avoid going barefoot because injuries may go unnoticed. Report wounds, redness, swelling, or infection promptly.[6]
- Sleep positioning: If bedsheet contact causes pain (allodynia), a bed cradle or foot tent can keep sheets off the feet while sleeping. This simple intervention dramatically improves sleep quality for many people.
- Temperature safety: Avoid heating pads, hot compresses, and extreme temperatures on numb skin. Check water temperature with an unaffected area or a thermometer to reduce burn risk.
- Exercise: Activity adapted to your abilities — such as walking, water exercise, or cycling — maintains muscle strength and balance that neuropathy threatens. Balance exercises specifically reduce fall risk. Avoid high-impact exercise that stresses already-damaged nerves.
- Mental health care: Chronic pain and depression are deeply bidirectional. Treating depression improves pain tolerance and pain outcomes. If neuropathic pain is affecting your mood — and it almost certainly is — that is a clinical concern worth addressing directly.
- Fall prevention: Numbness and balance problems increase fall risk significantly. Remove tripping hazards at home, use nightlights, consider handrails in the bathroom, and discuss balance assessment with your provider if you have fallen or feel unsteady.
Florida In Focus — Finding Neuropathy Care
🌴 Florida In Focus: Neuropathy Management
Neurology referrals through Ryan White: If your HIV provider has identified or suspects neuropathy, ask for a referral to a neurologist — and ask your Ryan White case manager whether neurology services are covered in your area. Ryan White Part B can fund specialty care for PLHIV including neurological evaluation.
Pain management through Ryan White: Some Ryan White programs can fund relevant clinical services; coverage and referrals vary locally. Ask specifically whether pain management services are available — not just your HIV medications.
University of Miami Miller School of Medicine: Ask about neurology referrals, current HIV-related expertise, appointments, and accepted coverage.
University of Florida Health (Gainesville): Neurology and HIV programs with experience in HIV neurological complications including neuropathy.
Community health centers: FQHCs across Florida can provide initial neuropathy evaluation and management — and can refer to neurology when needed. Find your nearest FQHC at fachc.org →
Use the RiseUpToHIV Florida Locator to find HIV care providers near you — many HIV specialty clinics have integrated neurology support.
References & Sources
- NIH/NINDS. Peripheral Neuropathy. Source.
- Cornblath and McArthur. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology, 1988. Source.
- Ellis et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. 2010. Source.
- NIH/NINDS. Causes and diagnosis of peripheral neuropathy. Source.
- Phillips et al. Pharmacological treatment of painful HIV-associated sensory neuropathy: systematic review and meta-analysis. PLOS ONE, 2010. Source.
- NIDDK. Diabetes and Foot Problems: protection from injuries and heat when sensation is reduced. Source.
- Hahn et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. Journal of Neurology, 2004. Source.
- Simpson et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology, 2010. Source.
- HRSA. Ryan White HIV/AIDS Program services. Source.
- HIVMA/IDSA. Chronic pain guideline: gabapentin, capsaicin, and limits of HIV-specific evidence. Source.
- NIH: Laboratory testing and the limits of HbA1c during ART. Source. Checked September 20, 2026. ↩
For the full list of organizations and studies that inform RiseUpToHIV, visit our Sources page.